PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19770794-0	2010	Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol.	Simvastatin	31-42	component of oligomeric golgi complex 2	Homo sapiens	95-130	
19770794-2	2010	We examined the association between switching from atorvastatin to simvastatin and changes in low-density lipoprotein cholesterol (LDL-C) levels in clinical practice.	Simvastatin	67-78	component of oligomeric golgi complex 2	Homo sapiens	94-129	
19770794-2	2010	We examined the association between switching from atorvastatin to simvastatin and changes in low-density lipoprotein cholesterol (LDL-C) levels in clinical practice.	Simvastatin	67-78	component of oligomeric golgi complex 2	Homo sapiens	131-136	
19770794-7	2010	Switched patients who were not prescribed a higher milligram dose of simvastatin were significantly less likely to reach an LDL-C less than 100 mg/dL (62.3% versus 74.0%; odds ratio, 0.55; 95% confidence interval, 0.36-0.84; P = 0.006) and had higher LDL-C (95.1 versus 87.2 mg/dL; P = 0.002) than control subjects.	Simvastatin	69-80	component of oligomeric golgi complex 2	Homo sapiens	124-129	
19770794-8	2010	A large proportion of patients who switch from atorvastatin to simvastatin are prescribed doses that are not therapeutically equivalent, and these patients were significantly less likely to meet LDL-C treatment goals compared with patients who remained on atorvastatin.	Simvastatin	63-74	component of oligomeric golgi complex 2	Homo sapiens	195-200